Search Results 531-540 of 21237 for anti-TNF drugs

  1. Milk thistle - Mayo Clinic

    Milk thistle may affect how your liver processes this osteoporosis medication, causing higher levels of the drug in your bloodstream. Talk to your doctor before ...

  2. SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry - Mayo Clinic

    Patient is currently receiving anti-TNF treatment for ≤12 months. Patient must receive anti-TNF treatment within 2 months following enrollment into the ...

  3. An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors - Mayo Clinic

    Open-label study using ASP-1929 photoimmunotherapy in combination with anti-PD1 therapy in patients with recurrent or metastatic head and neck and squamous cell ...

  4. Secukinumab (Intravenous Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

    Secukinumab injection is used to treat moderate to severe plaque psoriasis in patients who may benefit from receiving phototherapy (ultraviolet light treatment) ...

  5. Levoketoconazole (Oral Route) Before Using - Mayo Clinic

    Your doctor may decide not to treat you with this medication or change some of the other medicines you take. ... Adalimumab; Albendazole; Allopurinol; Alprazolam ...

  6. Cough And Cold Combinations (Oral Route) Description and Brand Names - Mayo Clinic

    The main expectorant used in cough and cold medicines is guaifenesin. Other ingredients added as expectorants (for example, ammonium chloride, calcium iodide, ...

  7. Triamterene And Hydrochlorothiazide (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  8. Antimyasthenic (Oral Route, Parenteral Route) Description and Brand Names - Mayo Clinic

    These medicines are available only with your doctor's prescription. This product is available in the following dosage forms: Tablet, Extended Release; Solution ...

  9. A Study to Identify a Panel of Biomarkers to Predict Response to Anti PD-1 Therapy - Mayo Clinic

    The purpose of this study is to identify a panel of possible biomarkers to predict response to anti PD-1 therapy by establishing the progression free survival ...

  10. Fulvestrant (Intramuscular Route) Description and Brand Names - Mayo Clinic

    It is also used to treat HR positive breast cancer that has progressed or worsened after hormonal therapy.